Ausgabe 4/2005
Inhalt (9 Artikel)
Pharmacokinetic and Pharmacodynamic Considerations in the Development of Therapeutic Proteins
Iftekhar Mahmood, Martin D. Green
Role of Cytochrome P450 Activity in the Fate of Anticancer Agents and in Drug Resistance
Bertrand Rochat
Pharmacokinetic/Pharmacodynamic Relationships of Asparaginase Formulations
Vassilios I. Avramis, Eduard H. Panosyan
Pharmacokinetics of Famotidine in Infants
Larissa A. Wenning, M. Gail Murphy, Laura P. James, Jeffrey L. Blumer, James D. Marshall, John Baier, Ann O. Scheimann, Deborah L. Panebianco, Ling Zhong, Roy Eisenhandler, Kuang C. Yeh, Gregory L. Kearns
Topiramate Pharmacokinetics in Children and Adults with Epilepsy
Dina Battino, Danilo Croci, Alessandro Rossini, Sara Messina, Daniela Mamoli, Emilio Perucca
Pharmacokinetic/Pharmacodynamic and Time-to-Event Models of Ribavirin-Induced Anaemia in Chronic Hepatitis C
Michel Tod, Muriel Farcy-Afif, Jeanick Stocco, Nathalie Boyer, Valérie Bouton, Martine Sinégre, Patrick Marcellin
Absence of Pharmacokinetic Interactions of the Combined Contraceptive Vaginal Ring NuvaRing® with Oral Amoxicillin or Doxycycline in Two Randomised Trials
Peter Dogterom, Michiel W. van den Heuvel, Torben Thomsen
Practical Guidelines to Interpret Plasma Concentrations of Antiretroviral Drugs
Jonathan Leith, Ralf Hinzmann, Douglas Mayers